The global Gene Editing Market region is characterized by immense intellectual property complexity and significant regulatory divergence, which together present unique operational challenges for multi-national organizations. The foundational patents for core editing technologies have been the subject of long and complex legal battles, necessitating intricate licensing agreements for companies...